Skip to main content
Premium Trial:

Request an Annual Quote

EGeen, Prediction Sciences Pen Pharmacogenomics Pact for Hypertension Drug Response

NEW YORK, Feb. 28 - EGeen International and Prediction Sciences plan to co-develop a diagnostic tool that can be used to help predict patient response to certain hypertension drugs.

Terms of the agreement call for Prediction Sciences to use its bioinformatics algorithms to compare patient chart information and SNP profiles with treatment outcomes. If successful, the collaboration will produce a tool that can be used in the clinic as "a predictive indicator of a patient's likelihood to respond to hypertension treatment."

Financial terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.